Nomura Asset Management CO LTD Beam Therapeutics Inc. Transaction History

Nomura Asset Management CO LTD

  • $31.8 Billion
  • Q3 2024

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$23.46 - $45.07 $0 - $0
0 New
0 $0
Q4 2023

Feb 09, 2024
BUY
$17.69 - $30.76 $0 - $0
0 New
0 $0
Q3 2023

Nov 03, 2023
BUY
$23.01 - $32.46 $0 - $0
0 New
0 $0
Q2 2023

Aug 14, 2023
BUY
$29.32 - $35.99 $0 - $0
0 New
0 $0
Q1 2023

May 11, 2023
BUY
$30.15 - $48.79 $0 - $0
0 New
0 $0
Q3 2021

Nov 12, 2021
SELL
$84.37 - $133.6 $0 - $0
0 Closed
0 $0
Q2 2021

Aug 06, 2021
BUY
$64.12 - $128.71 $0 - $0
0 New
0 $0
Q1 2021

May 14, 2021
BUY
$71.28 - $120.75 $0 - $0
0 New
0 $0
Q4 2020

Feb 12, 2021
BUY
$22.24 - $95.63 $0 - $0
0 New
0 $0

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.78B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email